Aethlon Medical Hemopurifier

At Manningham Medical Centre, you can find all the data about Aethlon Medical Hemopurifier. We have collected data about general practitioners, medical and surgical specialists, dental, pharmacy and more. Please see the links below for the information you need.

The Hemopurifier® in Infectious Disease - Aethlon …

https://www.aethlonmedical.com/the-hemopurifier/the-hemopurifier-in-infectious-disease

The Hemopurifier is an investigational device that has not yet received FDA approval for any indication. Aethlon continues to investigate the potential for the use of the Hemopurifier in viral diseases under an open Investigational Device Exemption (IDE) and our FDA Breakthrough Designation for “…the … See more

Aethlon Medical, Inc. (AEMD)

https://www.aethlonmedical.com/

The Aethlon Hemopurifier® is a first-in-class technology designed for the rapid depletion of circulating viruses and cancer-promoting exosomes. The United States Food and Drug …

Resources :: Aethlon Medical, Inc. (AEMD)

https://www.aethlonmedical.com/the-hemopurifier/resources

The Hemopurifier® captures infectious viruses by a protective glycan shield that viruses deploy to evade detection by the host immune system. The glycan shield …

Aethlon Medical Discloses Hemopurifier® Clinical Trial and ...

https://www.aethlonmedical.com/news-media/press-releases/detail/312/aethlon-medical-discloses-hemopurifier-clinical-trial-and

The Aethlon Hemopurifier® is a leading broad-spectrum treatment countermeasure against infectious viral pathogens. The device, which has been successfully administered to …

Investor Relations :: Aethlon Medical, Inc. (AEMD)

https://ir.aethlonmedical.com/

At present, the Hemopurifier® is being advanced in the United States under an FDA approved clinical study. Aethlon Medical is also investigating the potential use of the Hemopurifier® to reduce the …

FY2023 EPS Estimates for Aethlon Medical, Inc.

https://www.etfdailynews.com/2023/02/18/fy2023-eps-estimates-for-aethlon-medical-inc-nasdaqaemd-increased-by-analyst/

The consensus estimate for Aethlon Medical’s current full-year earnings is $0.64 per share. Zacks Small Cap also issued estimates for Aethlon Medical’s Q4 2023 …

Aethlon Medical Announces Contract with NAMSA to Advance …

https://www.aethlonmedical.com/news-media/press-releases/detail/455/aethlon-medical-announces-contract-with-namsa-to-advance

SAN DIEGO, Jan. 30, 2023 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical technology to treat cancer and life-threatening …

Aethlon Medical Announces Third Quarter Financial Results and …

https://finance.yahoo.com/news/aethlon-medical-announces-third-quarter-211500935.html

SAN DIEGO, Feb. 13, 2023 /PRNewswire/ -- Aethlon Medical, Inc. (NASDAQ: AEMD), a medical therapeutic company focused on developing products to …

Aethlon Medical Announces Contract with NAMSA to …

https://www.prnewswire.com/news-releases/aethlon-medical-announces-contract-with-namsa-to-advance-hemopurifier-clinical-programs-in-cancer-301732638.html

Aethlon Medical is a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases. The Hemopurifier is …

Need more information about Aethlon Medical Hemopurifier?

At Manningham Medical Centre, we collected data on more than just Aethlon Medical Hemopurifier. There is a lot of other useful information. Visit the related pages or our most popular pages. Also check out our Doctors page.